Teva to Pay $1.6 Billion to Settle Pfizer Patent Suit

Court ruled Teva, Sun sold generic heartburn drug Protonix before U.S. patent expired.

comments Print
Pfizer Inc. said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.